Actively Recruiting
Prognosis of Early-onset Anorexia Nervosa
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-02-03
140
Participants Needed
1
Research Sites
16 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The AM2P study aims to evaluate the long-term prognosis and quality of life of patients with early-onset anorexia nervosa, assessed 4 to 9 years after hospitalization. Prognosis will be determined using a composite outcome measure based on questionnaire responses and health indicators, including body mass index (BMI). In addition, the study will examine the patients' overall physical condition both at the time of assessment and during the interval between their last hospitalization and the present evaluation.
CONDITIONS
Official Title
Prognosis of Early-onset Anorexia Nervosa
Who Can Participate
Eligibility Criteria
You may qualify if you...
- First full hospitalization in the eating disorders unit (EDU) at Robert Debré Hospital and diagnosis of early-onset anorexia nervosa from 2016 to 2021
- No objection from the minor to participate in the study
- Proficiency and understanding of the French language
- Access to digital technology such as computer, smartphone, or tablet
You will not qualify if you...
- Primary diagnosis of avoidant/restrictive food intake disorder (ARFID) or other unspecified eating disorder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hopital Robert Debre - AP-HP
Paris, France, 75019
Actively Recruiting
Research Team
C
Coline STORDEUR, MD
CONTACT
A
Anael AYROLLES, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here